Medtronic, Inc. (NYSE: MDT) today announced the receipt of CE Mark (Conformité Européenne) and launch of the CapSure Sense MRI ™ SureScan ® pacing leads, which are approved for use during Magnetic ...
Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval for its Investigational Device Exemption (IDE) application and pivotal clinical trial protocol to begin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results